NCT07711496

Brief Summary

Effective control of postoperative pain following pediatric lower urogenital surgery is important for enhancing recovery and reducing opioid requirements. Anterior quadratus lumborum block and retrolaminar block are two ultrasound-guided truncal block techniques used for perioperative analgesia in lower abdominal surgery. However, direct comparisons of their analgesic efficacy in pediatric lower urogenital procedures remain limited. This prospective, randomized, controlled trial will enroll 76 pediatric patients aged 6 months to 12 years with American Society of Anesthesiologists physical status I-III who are scheduled for elective lower urogenital surgery. Participants will be randomly assigned in a 1:1 ratio to receive either an anterior quadratus lumborum block or a retrolaminar block. Both techniques will be performed under ultrasound guidance in addition to standardized general anesthesia. The primary outcome will be rescue analgesic requirement during the first 24 postoperative hours. Secondary outcomes will include postoperative pain scores, time to first rescue analgesic administration, intraoperative remifentanil consumption, adverse effects such as nausea and vomiting, and caregiver satisfaction. The study aims to compare the postoperative analgesic efficacy and safety of anterior quadratus lumborum block and retrolaminar block in pediatric patients undergoing lower urogenital surgery.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Jul 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress2%
Jul 2026Sep 2027

First Submitted

Initial submission to the registry

July 14, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 17, 2026

Completed
8 days until next milestone

Study Start

First participant enrolled

July 25, 2026

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2027

Expected
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2027

Last Updated

July 17, 2026

Status Verified

July 1, 2026

Enrollment Period

12 months

First QC Date

July 14, 2026

Last Update Submit

July 14, 2026

Conditions

Keywords

pediatric anesthesiapediatric regional anesthesiaretrolaminar blockpediatric pain management

Outcome Measures

Primary Outcomes (1)

  • Total Rescue Analgesic Requirement During the First 24 Postoperative Hours

    Total rescue analgesic consumption during the first 24 postoperative hours will be recorded. Pain assessment will be performed using the Face, Legs, Activity, Cry, and Consolability Scale. The scale ranges from 0 to 10, with higher scores indicating greater pain intensity. Rescue analgesia will be administered when the score is 4 or higher.

    First 24 hours after surgery

Secondary Outcomes (3)

  • Postoperative Pain Scores

    Postoperative 1, 2, 4, 8, 16, and 24 hours

  • Time to First Rescue Analgesic Administration

    First 24 hours after surgery

  • Intraoperative Remifentanil Consumption

    From induction of anesthesia until the end of surgery

Study Arms (2)

Anterior Quadratus Lumborum Block Group

EXPERIMENTAL

Participants assigned to this group will receive an ultrasound-guided anterior quadratus lumborum block following induction of general anesthesia for postoperative analgesia. The block will be performed under sterile conditions using 0.25 percent bupivacaine at a volume of 0.4 milliliters per kilogram. Standardized general anesthesia and postoperative analgesic protocols will be applied to all participants.

Procedure: Anterior Quadratus Lumborum Block

Retrolaminar Block Group

EXPERIMENTAL

Participants assigned to this group will receive an ultrasound-guided retrolaminar block following induction of general anesthesia for postoperative analgesia. The block will be performed under sterile conditions using 0.25 percent bupivacaine at a volume of 0.4 milliliters per kilogram. Standardized general anesthesia and postoperative analgesic protocols will be applied to all participants.

Procedure: Retrolaminar Block

Interventions

An ultrasound-guided retrolaminar block will be performed after induction of general anesthesia. After identification of the target vertebral lamina, 0.25 percent bupivacaine will be administered into the retrolaminar plane at a volume of 0.4 milliliters per kilogram.

Retrolaminar Block Group

An ultrasound-guided anterior quadratus lumborum block will be performed after induction of general anesthesia. Following identification of the quadratus lumborum and psoas major muscles, 0.25 percent bupivacaine will be injected into the fascial plane between these muscles at a volume of 0.4 milliliters per kilogram.

Anterior Quadratus Lumborum Block Group

Eligibility Criteria

Age6 Months - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 6 months and 12 years
  • Scheduled for lower abdominal urogenital surgery (e.g., inguinal hernia repair or orchiopexy for undescended testis)
  • American Society of Anesthesiologists physical status classification I-III
  • Written informed consent obtained from a parent or legal guardian

You may not qualify if:

  • History of allergy to local anesthetic agents
  • Presence of infection at the planned injection site
  • Coagulopathy or any other condition contraindicating regional anesthesia
  • Planned laparoscopic orchiopexy
  • American Society of Anesthesiologists physical status classification IV
  • Inability to obtain informed consent from a parent or legal guardian
  • Anticipated requirement for postoperative intensive care unit admission

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

Bakırköy, Istanbul, 34153, Turkey (Türkiye)

Location

Study Officials

  • münevver kayhan

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    PRINCIPAL INVESTIGATOR
  • Ayse Cigdem Tutuncu, Professor Doctor

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    STUDY DIRECTOR
  • Pinar Kendigelen, Professor Doctor

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    STUDY CHAIR

Central Study Contacts

münevver kayhan, Lecturer Doctor

CONTACT

Ayse Cigdem Tutuncu, Professor Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
The anesthesiologist responsible for evaluating eligibility criteria, monitoring intraoperative and postoperative pain scores and analgesic consumption, collecting study data, and performing statistical analyses will be blinded to group allocation. Participants and their caregivers will also remain blinded throughout the study. Randomization will be conducted by an independent investigator who will not be involved in patient recruitment, block performance, perioperative management, outcome assessment, or data analysis. Due to the nature of the interventions, the anesthesiologist performing the regional block procedures will be aware of group allocation and cannot be blinded. This anesthesiologist will not participate in postoperative assessments, data collection, or statistical analyses. Postoperative pain assessments on the ward will be performed every 4 hours by blinded nursing staff using the Face, Legs, Activity, Cry, and Consolability Scale. Patients with a score of 4 or greater w
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned in a 1:1 ratio to one of two parallel intervention groups. Patients in the first group will receive an ultrasound-guided anterior quadratus lumborum block, while patients in the second group will receive an ultrasound-guided retrolaminar block following induction of general anesthesia. Both blocks will be performed under standardized conditions using 0.25 percent bupivacaine at a volume of 0.4 milliliters per kilogram. Postoperative analgesic outcomes, rescue analgesic requirements, adverse events, and caregiver satisfaction will be compared between the two groups.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

July 14, 2026

First Posted

July 17, 2026

Study Start

July 25, 2026

Primary Completion (Estimated)

July 20, 2027

Study Completion (Estimated)

September 1, 2027

Last Updated

July 17, 2026

Record last verified: 2026-07

Data Sharing

IPD Sharing
Will not share

Locations